Department of Medicine
The Cambridge-GSK Translational Immunology Collaboration (https://www.gsk.com/en-gb/media/press-releases/gsk-and-cambridge-university-announce-new-five-year-collaboration-in-kidney-and-respiratory-disease/) is a new, interdisciplinary partnership between the University of Cambridge and GSK, bringing together expertise in immunology, AI and clinical development from both partners. The collaboration will focus on two disease areas: chronic kidney disease, estimated to affect 850 million people, roughly 10% of the world's population and chronic respiratory disease, affecting around 545 million people (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30157-0/fulltext).¿The mission of the collaboration is to accelerate research and development into immune-related diseases by applying cutting edge analytical technology and analytical expertise.